US Stock MarketDetailed Quotes

NUGX NUGENEREX IMMUNO-ONCOLOGY INC

Watchlist
  • 0.000100
  • 0.0000000.00%
15min DelayClose May 24 09:30 ET
10.03KMarket Cap-1P/E (TTM)

NUGENEREX IMMUNO-ONCOLOGY INC Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Apr 30, 2021
(Q2)Jan 31, 2021
(Q1)Oct 31, 2020
(FY)Jul 31, 2020
(Q4)Jul 31, 2020
(Q3)Apr 30, 2020
(Q2)Jan 31, 2020
(FY)Jul 31, 2019
(Q4)Jul 31, 2019
Assets
Current assets
Cash, cash equivalents and short term investments
--0
--0
--39
-78.41%84
-78.41%84
----
----
--389
--389
-Cash and cash equivalents
--0
--0
--39
-78.41%84
-78.41%84
----
----
--389
--389
Receivables
--5.11M
--1.8M
----
----
----
----
----
----
----
-Related party accounts receivable
--5.11M
--1.8M
----
----
----
----
----
----
----
Prepaid assets
--41.25K
----
--20K
----
----
----
----
----
----
Total current assets
3,993,150.39%5.15M
1,034,382.76%1.8M
--20.04K
-78.41%84
-78.41%84
--129
--174
--389
--389
Non current assets
Related parties assets
--5.11M
--1.8M
----
----
----
----
----
----
----
Total non current assets
--0
--0
--0
--0
--0
--0
--0
--0
--0
Total assets
3,993,150.39%5.15M
1,034,382.76%1.8M
--20.04K
-78.41%84
-78.41%84
--129
--174
--389
--389
Liabilities
Current liabilities
Payables
60.78%2.76M
32.84%2.21M
--1.88M
45.31%1.93M
45.31%1.93M
--1.72M
--1.67M
--1.33M
--1.33M
-accounts payable
259.90%1.45M
156.41%896.75K
--566.94K
4,803.81%614.35K
4,803.81%614.35K
--401.66K
--349.73K
--12.53K
--12.53K
-Other payable
0.00%1.32M
0.00%1.32M
--1.32M
0.00%1.32M
0.00%1.32M
--1.32M
--1.32M
--1.32M
--1.32M
Current accrued expenses
26.55%4.66M
26.99%4.4M
--4.15M
27.98%3.91M
27.98%3.91M
--3.68M
--3.46M
--3.06M
--3.06M
Current deferred liabilities
--6.3M
--1.8M
----
----
----
----
----
----
----
Current liabilities
154.10%13.72M
63.98%8.41M
--6.03M
33.23%5.84M
33.23%5.84M
--5.4M
--5.13M
--4.38M
--4.38M
Non current liabilities
Total non current liabilities
--0
--0
--0
--0
--0
--0
--0
--0
--0
Total liabilities
154.10%13.72M
63.98%8.41M
--6.03M
33.23%5.84M
33.23%5.84M
--5.4M
--5.13M
--4.38M
--4.38M
Shareholders'equity
Share capital
0.08%400.3K
0.08%400.3K
--400.3K
0.08%400.3K
0.08%400.3K
--400K
--400K
--400K
--400K
-common stock
-74.93%100.3K
0.08%400.3K
--400.3K
0.08%400.3K
0.08%400.3K
--400K
--400K
--400K
--400K
-Preferred stock
--300K
--0
--0
--0
--0
--0
----
--0
--0
Retained earnings
-16.58%-44.2M
-12.32%-42.24M
---40.16M
-4.31%-38.42M
-4.31%-38.42M
---37.92M
---37.61M
---36.83M
---36.83M
Paid-in capital
9.70%35.23M
9.82%35.23M
--33.75M
0.41%32.18M
0.41%32.18M
--32.12M
--32.08M
--32.05M
--32.05M
Total stockholders'equity
-58.71%-8.57M
-28.90%-6.61M
---6.01M
-33.24%-5.84M
-33.24%-5.84M
---5.4M
---5.13M
---4.38M
---4.38M
Total equity
-58.71%-8.57M
-28.90%-6.61M
---6.01M
-33.24%-5.84M
-33.24%-5.84M
---5.4M
---5.13M
---4.38M
---4.38M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
(Q3)Apr 30, 2021(Q2)Jan 31, 2021(Q1)Oct 31, 2020(FY)Jul 31, 2020(Q4)Jul 31, 2020(Q3)Apr 30, 2020(Q2)Jan 31, 2020(FY)Jul 31, 2019(Q4)Jul 31, 2019
Assets
Current assets
Cash, cash equivalents and short term investments --0--0--39-78.41%84-78.41%84----------389--389
-Cash and cash equivalents --0--0--39-78.41%84-78.41%84----------389--389
Receivables --5.11M--1.8M----------------------------
-Related party accounts receivable --5.11M--1.8M----------------------------
Prepaid assets --41.25K------20K------------------------
Total current assets 3,993,150.39%5.15M1,034,382.76%1.8M--20.04K-78.41%84-78.41%84--129--174--389--389
Non current assets
Related parties assets --5.11M--1.8M----------------------------
Total non current assets --0--0--0--0--0--0--0--0--0
Total assets 3,993,150.39%5.15M1,034,382.76%1.8M--20.04K-78.41%84-78.41%84--129--174--389--389
Liabilities
Current liabilities
Payables 60.78%2.76M32.84%2.21M--1.88M45.31%1.93M45.31%1.93M--1.72M--1.67M--1.33M--1.33M
-accounts payable 259.90%1.45M156.41%896.75K--566.94K4,803.81%614.35K4,803.81%614.35K--401.66K--349.73K--12.53K--12.53K
-Other payable 0.00%1.32M0.00%1.32M--1.32M0.00%1.32M0.00%1.32M--1.32M--1.32M--1.32M--1.32M
Current accrued expenses 26.55%4.66M26.99%4.4M--4.15M27.98%3.91M27.98%3.91M--3.68M--3.46M--3.06M--3.06M
Current deferred liabilities --6.3M--1.8M----------------------------
Current liabilities 154.10%13.72M63.98%8.41M--6.03M33.23%5.84M33.23%5.84M--5.4M--5.13M--4.38M--4.38M
Non current liabilities
Total non current liabilities --0--0--0--0--0--0--0--0--0
Total liabilities 154.10%13.72M63.98%8.41M--6.03M33.23%5.84M33.23%5.84M--5.4M--5.13M--4.38M--4.38M
Shareholders'equity
Share capital 0.08%400.3K0.08%400.3K--400.3K0.08%400.3K0.08%400.3K--400K--400K--400K--400K
-common stock -74.93%100.3K0.08%400.3K--400.3K0.08%400.3K0.08%400.3K--400K--400K--400K--400K
-Preferred stock --300K--0--0--0--0--0------0--0
Retained earnings -16.58%-44.2M-12.32%-42.24M---40.16M-4.31%-38.42M-4.31%-38.42M---37.92M---37.61M---36.83M---36.83M
Paid-in capital 9.70%35.23M9.82%35.23M--33.75M0.41%32.18M0.41%32.18M--32.12M--32.08M--32.05M--32.05M
Total stockholders'equity -58.71%-8.57M-28.90%-6.61M---6.01M-33.24%-5.84M-33.24%-5.84M---5.4M---5.13M---4.38M---4.38M
Total equity -58.71%-8.57M-28.90%-6.61M---6.01M-33.24%-5.84M-33.24%-5.84M---5.4M---5.13M---4.38M---4.38M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion with Explanatory Notes----------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg